Neurokinin-1 Receptor Antagonists: Review of Their Role for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults

Expert Review of Clinical Pharmacology - United Kingdom
doi 10.1080/17512433.2019.1621162
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Evolving Role of Neurokinin 1-Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting

OncoTargets and Therapy
OncologyPharmacology
2018English

Systematic Review of the Efficacy and Safety of Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: Identification of the Relevant Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Malignant tumours
2018English

Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: Approval and Efficacy

Cancer Management and Research
Oncology
2009English

Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Cannabinoids for Nausea and Vomiting in Adults With Cancer Receiving Chemotherapy

Cochrane Database of Systematic Reviews
2015English

Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic

BMJ
2001English

Dronabinol for Chemotherapy-Induced Nausea and Vomiting Unresponsive to Antiemetics

Cancer Management and Research
Oncology
2016English

Granisetron Transdermal System in the Management of Chemotherapy-Induced Nausea and Vomiting

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy